𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paracetamol disposition and metabolite kinetics in patients with chronic renal failure

✍ Scribed by L. F. Prescott; G. C. Speirs; J. A. J. H. Critchley; R. M. Temple; R. J. Winney

Publisher
Springer
Year
1989
Tongue
English
Weight
943 KB
Volume
36
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The disposition of paracetamol and the a
The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure
✍ U. Martin; R. M. Temple; R. J. Winney; L. F. Prescott πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 385 KB

We have compared the disposition of oral paracetamol (1.0 g t.d.s. for 10 days) in 6 healthy volunteers and 6 conservatively-managed patients with chronic renal failure (mean plasma creatinine 451 mumol.l-1). Blood was sampled daily for 10 days before the morning dose of paracetamol. Each day the pr

Disposition kinetics of disopyramide in
Disposition kinetics of disopyramide in patients with renal insufficiency
✍ Danny D. Shen; John L. Cunningham; Isami Shudo; Daniel L. Azarnoff πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 443 KB

The pharmacokinetics of an intravenous injection of disopyramide was studied in five normal subjects and six patients with varying degrees of renal impairment. The elimination rate constant (p) was related to the endogenous creatinine clearance (Cl,,). However, a decrease in / 3 was not observed un

Pharmacokinetics of oral diltiazem and f
Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure
✍ Maha Tawashi; Julien Marc-aurΓ¨le; Daniel Bichet; Jean SpΓ©nard; Lyne LariviΓ¨re; D πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 422 KB πŸ‘ 2 views

The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)